Are Panic Disorder Patients Switching from Medication to Cannabis?

PostedMarch 2, 2026

UpdatedMarch 2, 2026

ByMy Patient Advice

Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

Some patients with panic disorder are switching to cannabis as a potential alternative to traditional medications. For those seeking prescription alternatives, cannabinoids may offer relief from anxiety and panic symptoms while potentially reducing side effects associated with conventional treatments. Understanding panic disorder and switching to cannabis involves careful consideration of treatment transition strategies and guidance from healthcare professionals during tapering meds.

Managing the Transition

Professional supervision is essential when considering panic disorder and switching to cannabis to ensure safe and effective symptom management.

Prescription Alternatives

Cannabis may serve as a prescription alternative for patients who experience limited benefits or side effects from traditional medications.

Tapering Meds

Gradual tapering meds under medical supervision can help reduce withdrawal symptoms while transitioning to cannabis-based support.

Treatment Transition

Planning a treatment transition allows patients to safely integrate cannabis while maintaining control over panic disorder symptoms.

In conclusion, panic disorder and switching to cannabis can be an option for some patients, but professional guidance is critical to ensure safe, effective, and smooth treatment transition.

If you’re exploring cannabis treatment options for panic disorder, visit providers like LeafEase for personalised consultations and guidance tailored to your needs.

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Panic Disorder.

Julia Sutton, MSc

Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy.

Dr. Clarissa Morton, PharmD

Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy.